Matrix Metalloproteinase Inhibition Decreases Ischemia-Reperfusion Injury after Lung Transplantation

American Journal of Transplantation

Volumn 4, Issue 1, 2004, Pages 41-50

  Soccala, Paola M ^a,b   Gasche, Yvan ^b   Miniati, Douglas N ^c   Hoyt, Grant ^c   Berry, Gerald J ^a   Doyle, Ramona L ^a   Theodore, James ^a   Robbins, Robert C ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ischemia reperfusion; Lung transplantation; MMP; Rat

Indexed keywords

BATIMASTAT; GELATINASE A; GELATINASE B; GELATINASE INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY WALL; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GAS EXCHANGE; ISCHEMIA; LUNG ALVEOLUS; LUNG CAPILLARY; LUNG TRANSPLANTATION; MICROVASCULATURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANOXIA; CAPILLARIES; COLORING AGENTS; ENZYME INHIBITORS; EVANS BLUE; ISCHEMIA; LUNG; LUNG TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICROSCOPY, FLUORESCENCE; NEUTROPHILS; PEROXIDASE; PLACEBOS; RATS; RATS, INBRED F344; REPERFUSION INJURY; TIME FACTORS;

EID: 0742318927     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6135.2003.00277.x     Document Type: Article

References (57)

1. Christie JD, Bavaria JE, Palevsky HI et al. Primary graft failure following lung transplantation. Chest 1998; 114: 51-60.
2. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the international society for heart and lung transplantation: eighteenth official report, 2001. J Heart Lung Transplant 2001; 20: 805-815.
3. Qayumi AK, Nikbakht-Sangari M, Godin DV et al. The relationship of ischemia-reperfusion injury of transplanted lung and the upregulation of major histocompatibility complex II on host peripheral lymphocytes. J Thorac Cardiovasc Surg 1998; 115: 978-989.
4. Waddell TK, Gorczynski RM, DeCampos KN, Patterson GA, Slutsky AS. Major histocompatibility complex expression and lung ischemia-reperfusion in rats. Ann Thorac Surg 1996; 62: 866-872.
5. Crocetti JG, O'Brien OB, Furukawa S. The impact of reperfusion injury on the long term development of obliterative bronchiolitis (OB) in lung transplantation. Am J Respir Crit Care Med 2000; 161: A507.
6. Fiser SM, Tribble CG, Long SM et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002; 73: 1041-1048.
7. Fisher AJ, Donnelly SC, Hirani N et al. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet 1999; 353: 1412-1413.
8. Fisher AJ, Donnelly SC, Hirani N et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001; 163: 259-265.
9. Fischer S, Maclean AA, Liu M et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion injury in lung transplantation. Am J Respir Crit Care Med 2000; 162: 1932-1939.
10. Hidalgo MA, Shah PK, Fuller BJ, Green CJ. Cold ischemia-induced damage to vascular endothelium results in permeability alterations in transplanted lungs. J Thorac Cardiovasc Surg 1996; 112: 1027-1035.
11. Ichikawa H, Flores S, Kvietys PR et al. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circulation Res 1997; 81: 922-931.
12. Eberl T, Amberger A, Herold M et al. Expression of stress proteins, adhesion molecules, and interleukin-8 in endothelial cells after preservation and reoxygenation. Cryobiology 1999; 38: 106-118.
13. Hall SM, Evans J, Haworth SG. Influence of cold preservation on the cytoskeleton of cultured pulmonary arterial endothelial cells. Am J Respir Cell Mol Biol 1993; 9: 106-114.
14. Hall SM, Komai H, Reader J, Haworth SG. Donor lung preservation: effect of cold preservation fluids on cultured pulmonary endothelial cells. Am J Physiol 1994; 267 (5 Part 1): L508-L517.
15. Partridge CA. Hypoxia and reoxygenation stimulate biphasic changes in endothelial monolayer permeability 1995; 269: L52-L58.
16. Allport JR, Ding H, Collins T, Gerritsen ME, Luscinskas FW. Endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions. J Exp Med 1997; 186: 517-527.
17. Cepinskas G, Noseworthy R, Kvietys PR. Transendothelial neutrophil migration. Role of neutrophil-derived proteases and relationship to transendothelial protein movement. Circ Res 1997; 81: 618-626.
18. Mizgerd JP, Kubo H, Kutkoski GJ et al. Neutrophil emigration in the skin, lungs and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice. J Exp Med 1997; 186: 1357-1364.
19. Walker DC, Behzad AR, Chu F. Neutrophil migration through preexisting holes in the basal laminae of alveolar capillaries and epithelium during streptococcal pneumonia. Microvasc Res 1995; 50: 397-416.
20. Brown E. Neutrophil adhesion and the therapy of inflammation. Semin Hematol 1997; 34: 319-326.
21. Laurie GW, Leblond CP, Martin GR. Localization of type IV collagen, laminin, heparan sulfate proteoglycan and fibronectin to the basal lamina of basement membranes. J Cell Biol 1982; 95: 340-344.
22. Woessner JF, Nagase H. Matrix Metalloproteinases and Timps, 1st edn. New York: Oxford University Press; 2000.
23. Gearing AJH, Beckett P, Christodoulou M et al. Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature 1994; 370: 555-557.
24. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption. J Clin Invest 2000; 105: 143-150.
25. Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J Immunol 1998; 161: 3340-3346.
26. Ilan N, Mohsenin ALC, Madri JA. PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J 2001; 15: 362-372.
27. Von Bredow DC, Nagle RB, Bowden GT, Cress AE. Cleavage of β4 integrin by matrilysin. Exp Cell Res 1997; 236: 341-345.
28. Noe V, Fingleton B, Jacobs K et al. Release of an invasion promoter E-Cadherin fragment by matrylisin and stromelysin-1. J Cell Sci 2001; 114: 111-118.
29. Moore TM, Khimenko PL, Adkins WK, Miyasaka M, Taylor AE. Adhesion molecules contribute to ischemia and reperfusion-induced injury in the isolated rat lung. J Appl Physiol 1995; 78: 2245-2252.
30. Turegun M, Gudemez E, P. N. Zins J, Siemionow M. Blockade of platelet endothelial cell adhesion molecule-1 (PECAM-1) protects against ischemia-reperfusion injury in muscle flaps at microcirculatory level. Plast Reconstr Surg 1999; 104: 1033-1040.
31. Yan SF, Fujita T, Lu J et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6: 1355-1361.
32. Frisdal E, Teiger E, Lefaucheur JP et al. Increased expression of gelatinases and alteration of basement membrane in rat soleus muscle following femoral artery ligation. Neuropathol Appl Neurobiol 2000; 26: 11-21.
33. Gasche Y, Fujimura M, Morita-Fujimura Y et al. Early appearance of activated MMP-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999; 19: 1020-1028.
34. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998; 29: 2189-2195.
35. Weiss SJ, Peppin GJ. Collagenolytic metalloenzymes of the human neutrophil: regulation and potential function in vivo. Biochem Pharmacol 1986; 35: 3189-3197.
36. Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999; 842: 92-100.
37. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R. Matrix-metalloproteinase-2 contributes to ischemiareperfusion injury in the heart. Circulation 2000; 101: 1833-1839.
38. Danielsen CC, Wiggers H, Andersen HR. Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. J Mol Cell Cardiol 1998; 30: 1431-1442.
39. Lindsey M, Wedin K, Brown MD et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 2001; 103: 2181-2187.
40. Upadhya AG, Harvey RP, Howard TK, Lowell JA, Shenoy S, Strasberg SM. Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. Hepatology 1997; 26: 922-928.
41. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size 1998; 29: 1020-1030.
42. Falk V, Soccal PM, Grunenfelder J, Hoyt G, Walther T, Robbins RC. Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury. Eur J Cardiothorac Surg 2002; 22: 53-58.
43. Soccal PM, Gasche Y, Pache J-C et al. Metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury. Transplantation 2000; 70: 998-1005.
44. Yano M, Omoto Y, Yamakawa Y et al. Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury. J Heart Lung Transplant 2001; 20: 679-686.
45. Prop J, Ehrie MG, Crapo JD, Nieuwenhuis CP, Wildewur CRH. Reimplantation response in isografted rat lungs. J Thorac Cardiovasc Surg 1984; 87: 702-711.
46. Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2001; 21: 1393-1400.
47. Patterson C, Rhoades R, Garcia R. Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol 1992; 72: 865-873.
48. Sato H, Seiki M. Regulatory mechanism of 92-kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.
49. Partridge A, Jeffrey JJ, Malik AB. A 96-kDa gelatinase induced by TNFα contributes to increased microvascular endothelial permeability. Am J Physiol 1993; 265: L438-L447.
50. Hayashi T, Stettler-Stevenson WG, Fleming MV et al. Immunohistological study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996; 149: 1241-1256.
51. Koike K, Moore EE, Moore FA, Read RA, Carl VS, Banerjee A. Gut ischemia/reperfusion produces lung injury independent of endotoxin. Crit Care Med 1994; 22: 1438-1444.
52. Tschesche H, Bakowski B, Schettler A, Knäuper V, Reinke H, Krämer S. Leukodiapedesis, compartmentalisation and secretion of PMN leukocyte proteinases and activation of PMN leukocyte procollagenase. Biomed Biochem Acta 1991; 50: 755-761.
53. Mignatti P, Tsuboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 1989; 108: 671-682.
54. Delclaux C, Delacourt C, d'Ortho M-P, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14: 288-295.
55. Mackarel AJ, Cottell DC, Russell KJ, FitzGerald MX, O'Connor CM. Migration of neutrophils across human pulmonary endothetial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am J Respir Cell Mol Biol 1999; 20: 1209-1219.
56. Betsuyaku T, Shipley JM, Liu Z, Senior RM. Neutrophil emigration in the lungs, peritoneum and skin does not require gelatinase B. Am J Respir Cell Mol Biol 1999; 20: 1303-1309.
57. Stracke JO, Hutton M, Stewart M et al. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. J Biol Chem 2000; 275: 14809-14816.